Ophthalmological manifestations of neuroblastoma – A retrospective multicenter study

Neuroblastoma (NBL) constitutes the most common extracranial solid tumor in children that arises from the sympathetic ganglia. Its manifestations depend on the localization of the tumor and metastases. This research aimed to assess the incidence of ophthalmological symptoms and their correlations with different prognostic factors. We collected and analyzed retrospectively the data of 776 children with a clinical diagnosis of peripheral neuroblastic tumors reported between 2004 and 2022 from 14 Polish pediatric oncology centers. Ophthalmological symptoms occurred in 17.10% of the patients, and in 12.70% they were diagnosed at the time of the first presentation. The reported manifestations comprised opsoclonus-myoclonus syndrome (OMS), Horner syndrome (HS), exophthalmos, periorbital hemorrhages, with the highest incidence of OMS (4.74% of all the patients). Moreover, we described the cases with neurological manifestations of NBL like paraparesis and facial nerve paresis. The age correlated with the form of symptoms, and HS was observed in the youngest patients. Similarly, the time from the symptoms onset to NBL diagnosis differed significantly among the patients, therefore the diagnosis of HS was associated with the longest period. In conclusion, the ophthalmological manifestations of NBL represent an essential group of symptoms. Therefore, clinicians should consider them as possible signs of tumors, particularly HS, which may be most challenging in the diagnostic process.

Authors

Institutions

Publication Details

Journal
Pediatric Hematology and Oncology
Published
2026-04-14
DOI
https://doi.org/10.1080/08880018.2026.2650745
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ophthalmological manifestations of neuroblastoma – A retrospective multicenter study

Szymon Janczar, Bożenna Dembowska–Bagińska, Katarzyna Drabko, Katarzyna Kuchalska et al.
Pediatric Hematology and Oncology
Neuroblastoma Research and Treatments
article

Ophthalmological manifestations of neuroblastoma – A retrospective multicenter study

Szymon Janczar, Bożenna Dembowska–Bagińska, Katarzyna Drabko, Katarzyna Kuchalska, Marek Ussowicz, Walentyna Balwierz, Katarzyna Machnik, Tomasz Szczepański, Wanda Badowska, Aleksandra Kiermasz, Monika Pogorzała, Bartosz Urbański, Anna Pytlik, Anna Tomoń, Julia Geisler-Paliwoda, Krzysztof Kałwak, Szymon Skoczeń, Danuta Januszkiewicz-Lewandowska, Jan Styczyński, Małgorzata Sawicka-Żukowska, Ninela Irga-Jaworska, Katarzyna Muszyńska-Rosłan, Agnieszka Mizia-Malarz, Anna Gotz-Więckowska, Katarzyna Derwich, Radosław Chaber
article en

Abstract

Neuroblastoma (NBL) constitutes the most common extracranial solid tumor in children that arises from the sympathetic ganglia. Its manifestations depend on the localization of the tumor and metastases. This research aimed to assess the incidence of ophthalmological symptoms and their correlations with different prognostic factors. We collected and analyzed retrospectively the data of 776 children with a clinical diagnosis of peripheral neuroblastic tumors reported between 2004 and 2022 from 14 Polish pediatric oncology centers. Ophthalmological symptoms occurred in 17.10% of the patients, and in 12.70% they were diagnosed at the time of the first presentation. The reported manifestations comprised opsoclonus-myoclonus syndrome (OMS), Horner syndrome (HS), exophthalmos, periorbital hemorrhages, with the highest incidence of OMS (4.74% of all the patients). Moreover, we described the cases with neurological manifestations of NBL like paraparesis and facial nerve paresis. The age correlated with the form of symptoms, and HS was observed in the youngest patients. Similarly, the time from the symptoms onset to NBL diagnosis differed significantly among the patients, therefore the diagnosis of HS was associated with the longest period. In conclusion, the ophthalmological manifestations of NBL represent an essential group of symptoms. Therefore, clinicians should consider them as possible signs of tumors, particularly HS, which may be most challenging in the diagnostic process.

Pediatric Hematology and OncologyVol. 43(3-4)
Poznan University of Medical Sciences (PL), Medical University of Lublin (PL), Jagiellonian University (PL), Medical University of Białystok (PL), Medical University of Silesia (PL), Nicolaus Copernicus University (PL), Wroclaw Medical University (PL), Children's Memorial Health Institute (PL), Medical University of Lodz (PL), County Hospital (GB), Collegium Medicum in Bydgoszcz (PL), Moscow City Oncology Hospital №62 (RU), Gdańsk Medical University (PL), University of Rzeszów (PL)
Good health and well-being
Openalex Percentile: Top 23%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.